Fiduciary/Claymore Infrastructure Fund EBITDA margin
Cos'è EBITDA margin di Fiduciary/Claymore Infrastructure Fund?
EBITDA margin di Fiduciary/Claymore Energy Infrastructure Fund è -466.20%
Qual è la definizione di EBITDA margin?
EBITDA margin is a profitability ratio that measures how much EBITDA the company generates as a percentage of revenue.
ttm (trailing twelve months)
EBITDA margin measures how much of EBITDA is generated as a percentage of sales. It measures the company’s operating profit as a percentage of its revenue and is calculated as EBITDA (earnings before interest, taxes, depreciation, and amortization) divided by total revenue.
EBITDA margin also helps with judging the effectiveness of cost-cutting processes at the company. The higher the company’s EBITDA margin, the lower operating expenses are in respect to revenue. As a result, a higher EBITDA margin is considered more favorable. Smaller companies can have higher EBITDA margins since they are able to operate more efficiently and maximize their profitability.
EBITDA excludes interest on debt, taxes, and capital expenditures, the margin does not provide a perfectly clear estimate of the business’s cash flow generation. Furthermore, EBITDA margin is not recognized as a GAAP (generally accepted accounting principles) metric.
EBITDA margin di aziende nel Finance settore su NYSE rispetto a Fiduciary/Claymore Infrastructure Fund
Cosa fa Fiduciary/Claymore Infrastructure Fund?
Fiduciary/Claymore Energy Infrastructure Fund is a closed ended equity mutual fund launched and managed by Guggenheim Funds Investment Advisors, LLC.
Aziende con ebitda margin simili a Fiduciary/Claymore Infrastructure Fund
- Theralase Technologies ha EBITDA margin di -476.04%
- Sangamo Therapeutics Inc ha EBITDA margin di -474.14%
- Xinyang Maojian ha EBITDA margin di -471.45%
- WANdisco Plc ha EBITDA margin di -470.42%
- RYU Apparel ha EBITDA margin di -468.27%
- Barra Resources ha EBITDA margin di -466.28%
- Fiduciary/Claymore Infrastructure Fund ha EBITDA margin di -466.20%
- SRAX Inc ha EBITDA margin di -465.79%
- Xtract One Technolgies Inc ha EBITDA margin di -464.36%
- Spruce Biosciences ha EBITDA margin di -462.16%
- Sage Therapeutics Inc ha EBITDA margin di -460.83%
- Arcimoto Inc ha EBITDA margin di -460.40%
- Canopy Rivers ha EBITDA margin di -458.36%